Diagnostic Testing Of Stds Market Witnessing Growth Due To Rapid Adoption Of Point-ofCare Diagnostic Tests
Diagnostic testing of sexually transmitted diseases (STDs) plays a pivotal role in the prevention and treatment of various STDs such as HIV/AIDS, syphilis, gonorrhea, chlamydia, and others. STD diagnostic testing involves various techniques such as nucleic acid amplification tests (NAATs), enzyme immunoassays (EIAs), rapid point-of-care tests, and microfluidics. Nucleic acid amplification tests (NAATs) are considered gold-standard tests owing to their high sensitivity and specificity.
The global diagnostic testing of STDs market is estimated to be valued at US$ 12.5 Bn in 2024 and is expected to exhibit a CAGR of 9.6% over the forecast period 2024 to 2031.
https://www.newsstatix.com...
Diagnostic testing of sexually transmitted diseases (STDs) plays a pivotal role in the prevention and treatment of various STDs such as HIV/AIDS, syphilis, gonorrhea, chlamydia, and others. STD diagnostic testing involves various techniques such as nucleic acid amplification tests (NAATs), enzyme immunoassays (EIAs), rapid point-of-care tests, and microfluidics. Nucleic acid amplification tests (NAATs) are considered gold-standard tests owing to their high sensitivity and specificity.
The global diagnostic testing of STDs market is estimated to be valued at US$ 12.5 Bn in 2024 and is expected to exhibit a CAGR of 9.6% over the forecast period 2024 to 2031.
https://www.newsstatix.com...
3 months ago
